They're turning into active participants in a global conversation about weight loss and health Picture this: A patient stumbles upon a TikTok video of someone sharing their positive experience with Wegovy
Tirzepatide works by allowing GIP and GLP-1 to stimulate the pancreas to increase the amount of insulin released in response to meals, encouraging healthy blood glucose regulation
Si el tratamiento con aGLP-1 ya estaba establecido, es posible comenzar con la dosis de mantenimiento del nuevo medicamento, sin necesidad de utilizar las dosis de inicio
Shin H, Jeong S, Lee Y, Jeon C, Kwon G, Kim S, et al
Research Overview Retatrutide is a next-generation multi-agonist peptide that engages GIP, GLP-1 and glucagon receptors simultaneously